The Swiss drug maker Roche is buying InterMune, a specialist in treatments for breathing diseases, for $8.3 billion, as pharmaceutical firms continue to seek new products to bolster their ... Read More
We use cookies to improve your browsing experience on our website. To find out more, please read our Privacy Policy and Cookies Policy, been updated and became effective May 24, 2018.
By continuing to navigate our website without changing your cookies settings, or by clicking 'Ok', you hereby acknowledge and agree to OneStopBrokers use of cookies.OkRead more